Toggle light / dark theme

Antibacterial and Immunostimulatory Activity of Potential Probiotic Lactic Acid Bacteria Isolated from Ethiopian Fermented Dairy Products

Lactic acid bacteria (LAB) form a group of bacteria to which most probiotics belong and are commonly found in fermented dairy products. Fermented foods and beverages are foods made through desired microbial growth and enzymatic conversions of food components. In this study, 43 LAB were isolated from Ethiopian traditional cottage cheese, cheese, and yogurt and evaluated for their functional and safety properties as candidate probiotics. Twenty-seven isolates, representative of each fermented food type, were selected and identified to the species level. Limosilactobacillus fermentum was found to be the predominant species in all samples studied (70.4%), while 11.1% of isolates were identified as Lactiplantibacillus plantarum. All 27 isolates tested showed resistance to 0.5% bile salt, while 26 strains were resistant to pH 3.

Body image issues in adolescence are linked to depression in adulthood, twin study finds

Teenagers who are unhappy with their bodies are more likely to develop symptoms of eating disorders and depression in early adulthood, according to a new study led by University College London (UCL) researchers.

The research, believed to be the first of its kind, followed more than 2,000 twins born in England and Wales. It found that higher body dissatisfaction at age 16 predicted greater symptoms of eating disorders and depression well into the twenties, even after taking into account family background and genetics.

Researchers say the findings strengthen evidence that a negative body image is not just a reflection of poor mental health, but that it can also contribute to it.

Medications change our gut microbiome in predictable ways

The bacteria in our poop are a reasonable representation of what’s living in our digestive system. To understand how different drugs can impact the gut microbiome, the team cultured microbial communities from nine donor fecal samples and systematically tested them with 707 different clinically relevant drugs.

The researchers examined changes in the growth of different bacterial species, the community composition, and the metabolome – the mix of small molecules called metabolites that microbes produce and consume. They found that 141 drugs altered the microbiome of the samples and even short-term treatments created enduring changes, entirely wiping out some microbial species. The primary force behind how the community responds to drug inhibition was competition over nutrients.

“The winners and losers among our gut bacteria can often be predicted by understanding how sensitive they are to the medications and how they compete for food,” said the first author on the paper. “In other words, drugs don’t just kill bacteria; they also reshuffle the ‘buffet’ in our gut, and that reshuffling shapes which bacteria win.”

Despite the complexity of the bacterial communities, the researchers were able to create data-driven computer models that accurately predicted how they would respond to a particular drug. They factored in the sensitivity of different bacterial species to that drug and the competitive landscape – essentially, who was competing with whom for which nutrients.

Their work provides a framework for predicting how a person’s microbial community might change with a given drug, and could help scientists find ways to prevent these changes or more easily restore a healthy gut microbiome in the future.


Our gut microbiome is made up of trillions of bacteria and other microbes living in our intestines. These help our bodies break down food, assist our immune system, send chemical signals to our brain, and potentially serve many other functions that researchers are still working to understand. When the microbiome is out of balance – with not enough helpful bacteria or the wrong combination of microbes – it can affect our whole body.

Ozempic can reduce metabolic risks in schizophrenia patients, multicenter study finds

Semaglutide medications like Ozempic and Wegovy can help lower the risk of heart and metabolic diseases in people with schizophrenia spectrum disorders, according to a study published in JAMA Psychiatry.

Glucagon-like peptide–1 receptor agonist (GLP-1RAs) drugs, such as semaglutide, mimic the natural gut hormone GLP-1 that regulates hunger and food intake. By activating GLP-1 receptors in the brain, the drug reduces hunger and slows gastric emptying, helping one feel full longer. It also enhances glucose-dependent insulin secretion, thereby improving blood sugar control.

Researchers in Denmark recruited 73 adults taking antipsychotic medications who were showing early signs of diabetes and had an average BMI of 36, which falls in the category of obesity. The participants, aged 18 to 65 years, were randomly assigned to receive either weekly semaglutide injections or a placebo for 6.5 months.

Gene editing creates compact goldenberry plants suitable for large-scale farming

Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly popular in U.S. grocery stores. But the plants that produce these bright yellow-orange fruits grow wild and unruly—reaching heights that make large-scale farming impractical.

Researchers at the Boyce Thompson Institute (BTI) helped solve that problem. Using CRISPR gene editing, a collaborative team including BTI professor Joyce Van Eck engineered compact goldenberry plants that are 35% shorter than their wild relatives, making them viable for commercial agriculture.

“Goldenberry has tremendous potential as a nutritious crop, but its large, bushy growth habit has hindered commercial production,” said Van Eck. “These new compact plants can be grown at higher density, don’t require extensive staking or trellising, and are much easier to maintain and harvest.”

Bio-hybrid robots turn food waste into functional machines

EPFL scientists have integrated discarded crustacean shells into robotic devices, leveraging the strength and flexibility of natural materials for robotic applications.

Although many roboticists today turn to nature to inspire their designs, even bioinspired robots are usually fabricated from non-biological materials like metal, plastic and composites. But a new experimental robotic manipulator from the Computational Robot Design and Fabrication Lab (CREATE Lab) in EPFL’s School of Engineering turns this trend on its head: its main feature is a pair of langoustine abdomen exoskeletons.

Although it may look unusual, CREATE Lab head Josie Hughes explains that combining biological elements with synthetic components holds significant potential not only to enhance robotics, but also to support sustainable technology systems.

Tracking forever chemicals across food web shows not all isomers are distributed equally

When University at Buffalo chemists analyzed samples of water, fish, and bird eggs, they weren’t surprised to find plenty of per- and polyfluoroalkyl substances (PFAS). After all, these “forever chemicals” turn up nearly everywhere in the environment.

Tooth–bone attachment tissue is produced by cells with a mixture of odontoblastic and osteoblastic features in reptiles

Several types of tooth–bone attachment have evolved in different branches of amniotes. The most studied type of tooth anchorage is thecodont implantation, characterized by a nonmineralized periodontal ligament linking the tooth to the jawbone inside a deep alveolus (Bertin et al., 2018 ; Diekwisch, 2001). This attachment, called gomphosis, is present in mammals and crocodilians and provides robust resistance to mechanical stress during food processing (McIntosh et al., 2002).

By contrast, the teeth of recent lepidosaurian reptiles are firmly attached to the jaw bones, although the morphology of this type of attachment varies across species (Gaengler, 2000). In most lizards and snakes, teeth are ankylosed to the inner side of the high labial wall of the jawbone (pleurodont attachment). However, in some species (e.g., agamas, chameleons), the teeth are completely fused to the crest of the tooth-bearing bone (acrodont teeth) (Edmund, 1960). Such cases, where the teeth are firmly fused to the tooth-bearing element by mineralized tissue, are called ankylosis (for nomenclature, see a recent review by Bertin et al., 2018). Although ankylosis is widespread in nature, in mammals, a fusion of the tooth to the bone by hard tissue is considered a pathological condition (Palone et al., 2020 ; Tong et al., 2020).

Diverse developmental mechanisms have been proposed to explain the evolutionary origin and elaboration of ankylosis. The first developmental step of ankylosis is described as a soft ligament mineralization (LeBlanc et al., 2016 ; Liu et al., 2016). The periodontal ligaments in ancestral mammals have been predicted to display a high osteogenic potential, with an inclination to become calcified, thus resulting in dental ankylosis (LeBlanc et al., 2016). The mineralized ligamentous tissue has been preserved in fossilized mosasaurs, and it is also evident in several fish species and modern snakes (LeBlanc, Lamoureux, & Caldwell, 2017 ; Luan et al., 2009 ; Peyer, 1968). In the second type, ankylosis has been described as developing without ligament formation, with the tooth base firmly attached directly to the top of the tooth-bearing bony pedicles with no sign of previous ligament production (Buchtová et al., 2013 ; Luan et al., 2009).

Hormone-disrupting chemicals from plastics shown to promote a chronic inflammatory skin condition

A Johns Hopkins Medicine study involving a dozen people with the inflammatory skin disease hidradenitis suppurativa (HS), which mostly affects skin folds, is believed to be the first to provide evidence that hormone-disrupting chemicals commonly found in ultra-processed food and single-use water bottles may contribute to the development of or worsen the condition in some people.

The new findings about the disorder build on previous reports about the role of endocrine-disrupting chemicals, a common environmental contaminant known to mimic, block or alter the body’s hormones, in human health. Researchers believe their findings suggest that reducing exposure could ease HS symptom severity and provide a new avenue of relief for a disease with limited FDA-approved treatment options that include biologic therapy and surgery.

The full report on the study was published in Nature Communications on Nov. 28 and includes insights into the molecular mechanisms that are involved in the disease.

/* */